SERPINB11抗体—艾普蒂

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Mouse lung tissue, Primary antibody: P08761(SERPINB11 Antibody) at dilution 1/400, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 30 seconds    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P08761(SERPINB11 Antibody) at dilution 1/20. (Original magnification: ×200)    

  
  

SERPINB11 (Serpin Family B Member 11) is a member of the serine protease inhibitor (serpin) superfamily, which regulates proteolytic enzymes involved in diverse biological processes, including inflammation, apoptosis, and tissue remodeling. This protein is encoded by the SERPINB11 gene and is primarily expressed in epithelial tissues. While its exact physiological role remains under investigation, SERPINB11 is hypothesized to inhibit specific serine proteases, modulating cellular pathways linked to disease states such as cancer, immune disorders, and skin pathologies. Dysregulation of SERPINB11 has been observed in certain cancers, suggesting potential roles in tumor progression or metastasis.

SERPINB11 antibodies are immunological tools designed to detect and quantify SERPINB11 protein expression in research applications. These antibodies are typically developed using recombinant SERPINB11 protein or peptide immunogens and validated for techniques like Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and ELISA. They enable researchers to study SERPINB11's tissue distribution, subcellular localization, and expression patterns under various physiological or pathological conditions. Specific antibodies may also help investigate interactions with proteases or other binding partners, shedding light on its regulatory mechanisms. As SERPINB11 gains attention in biomarker discovery and therapeutic targeting, its antibodies serve as critical reagents for exploring its diagnostic or therapeutic potential in diseases like squamous cell carcinoma and chronic inflammatory disorders.